Regular ArticleRationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy
References (71)
Clinical hyperthermia and chemotherapy
Radiol Clin N America
(1989)- et al.
Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: pharmacokinetics and cisplatin-DNA adduct formation in patients and ovarian cancer cell lines
Eur J Cancer
(1998) - et al.
Peritonectomy and hyperthermic antiblast perfusion in the treatment of peritoneal carcinomatosis
Eur J Surg Onc
(2000) - et al.
Effects of intraperitoneal chemotherapy on anastomotic healing in the rat
J Surg Res
(1991) - et al.
Peritoneal carcinomatosis treatment with curative intent: the Institut Gustave-Roussy experience
Eur J Surg Onc
(1997) - et al.
Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination
Surgery
(1996) - et al.
Use of nitrogen mustard in treatment of serous effusions of neoplastic origin
JAMA
(1955) - et al.
Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer
Cancer Treat Rep
(1978) - et al.
High volume intraperitoneal chemotherapy (“belly bath”) for ovarian cancer. Pharmacologic basis and early results
Cancer Chemother Pharmacol
(1978) - et al.
Long-term survival of advanced refractory ovarian carcinoma patients with small-volume disease treated with intraperitoneal chemotherapy
J Clin Oncol
(1987)
Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer
N Engl J Med
(1996)
Intraperitoneal treatment and dose-intense therapy in ovarian cancer
Ann Oncol
(1999)
Role of cytoreductive surgical treatment in the management of advanced ovarian cancer
Cancer Treat Rep
(1979)
Secondary cytoreductive surgery for recurrent ovarian cancer. A prospective study
Cancer
(1995)
Peritonectomy procedures
Ann Surg
(1995)
Pseudomyxoma peritonei syndrome
Adv Surg
(1996)
The treatment of malignancy by hyperthermia
Surg Oncol
(1999)
Status of clinical hyperthermia
Acta Oncol
(1999)
An update on the anticancer effects of a combination of chemotherapy and hyperthermia
Cancer Res
(1984)
Hyperthermic peritoneal perfusion system in canines
Cancer Res
(1980)
Clinical delivery system for intraperitoneal hyperthermic chemotherapy
Cancer Res
(1980)
Methodologic considerations in treatment using intraperitoneal chemotherapy
Cancer Treat Res
(1996)
Management of peritoneal-surface malignancy: the surgeon's role
Langenbecks Arch Surg
(1999)
Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: randomised controlled study
World J Surg
(1994)
Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination
World J Surg
(1991)
Thermic homogeneity and standardization of intraperitoneal chemohyperthermia for peritoneal carcinomatosis
Reg Cancer Treat
(1996)
Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding
Ann Surg
(1988)
Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin-C
Cancer
(1988)
Peritoneal expansion by artificially produced ascites during perfusion chemotherapy
Arch Surg
(1999)
Effects ofintra-abdominal pressure on pharmacokinetics and tissue distribution of doxorubicin after intraperitoneal administration
Anticancer Drugs
(1996)
Surgically directed chemotherapy: heated intraperitoneal lavage with mitomycin C
Cancer Treat Res
(1996)
Long term survival of 5 years following initial surgery for gastric cancer and simultaneous disseminated peritoneal metastasis
Surg Today
(1995)
Does hyperthermia induce peritoneal damage in continuous hyperthermic peritoneal perfusion
World J Surg
(2000)
Peritoneal-plasma barrier
Cancer Treat Res
(1196)
The minimal importance of hollow viscera to peritoneal transport during peritoneal dialysis in the rat
Am Soc Artif Intern Organs Transact
(1988)
Cited by (217)
The many faces of intraperitoneal chemotherapy
2022, Surgical OncologyDisparities in the Management of Peritoneal Surface Malignancies
2022, Surgical Oncology Clinics of North AmericaRole of intraperitoneal chemotherapy in gastric cancer
2021, Surgery in Practice and ScienceRisk factors of chronic kidney disease in cisplatin-based hyperthermia intraperitoneal chemotherapy
2024, International Journal of Hyperthermia
- f1
Correspondence to: F.A.N. Zoetmulder MD PhD, Department of General Surgery, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam. Tel.: +31/20 512 2550; Fax: +31-20 512 2554; E-mail:[email protected]
Copyright © 2001 Harcourt Publishers Ltd. All rights reserved.